Recombinant Marek's disease virus strain SCA13 strain and application thereof
A Marek virus and strain technology, applied in the field of animal virology, can solve the problem of poor immune effect, and achieve the effect of good immune protection and good horizontal transmission ability.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] Example 1: Isolation and identification of recombinant MDV
[0045] Select well-developed SPF chicken embryos at the age of 9-10 days, and disinfect the eggshells at the air chamber with iodine cotton in the ultra-clean bench, and prepare chicken embryo fibroblasts (CEF) by conventional methods, according to 5 million / cell The concentration of the bottle was inoculated in the square bottle of cell culture (35cm 2 ), placed at 37°C, 5% carbon dioxide (CO 2 ) in an incubator, and after the cells grow into a single layer, they are replaced with a maintenance solution (1% newborn bovine serum, 500 IU / mL penicillin and streptomycin, 2 IU / mL amphotericin) for later use.
[0046] 1ml of anticoagulant blood was aseptically collected from chickens with obvious clinical symptoms of MD in flocks. Thoroughly mix the blood with an equal volume of PBS buffer, slowly add 2ml of lymphocyte separation solution along the tube wall, and centrifuge at 400g for 15min. Collect lymphocyte ...
Embodiment 2
[0047] Embodiment 2: Pathogenicity test of recombinant MDV SCA13 strain
[0048] Sixty-five 1-day-old SPF chickens were randomly divided into four groups and housed in positive pressure isolation hoods. In the first group of 20 SPF chickens, 15 SPF chickens were intraperitoneally injected with SCA13 strain MDV at a dose of 2000 PFU / bird at the age of 1 day, and immunized with NDV and AIV-H9 inactivated vaccine at the age of 7 days. The other 5 chickens were left without any treatment and marked for detection of the lateral transmission ability of the SCA13 strain and the stability of the ALV LTR fragment in the genome of the SCA13 strain during the contact infection process. In the second group, 15 SPF chickens were vaccinated with NDV and AIV-H9 inactivated vaccine at the age of 7 days, and served as the blank control group. After 4w and 5w after immunization, the blood separation serum of the two groups of chickens was collected, and the antibody titers of AIV-H9 and NDV of...
Embodiment 3
[0054] Embodiment 3: Construction and identification of recombinant MDV SDL161 strain
[0055] 1. Construction of BAC clone of MDV SCA13 strain
[0056] Take 1 μg of CEF DNA infected by SCA13 strain and 2.5 μg of pDS-pHAI-US2 plasmid DNA to co-transfect primary CEF. After 6 days, the transfected diseased cells were digested with 0.05% trypsin, and inoculated into culture medium containing 8× 10 6 In a T75 cell flask of CEF, 37°C﹑5%CO 2 After culturing for 5 days, the infected CEFs were digested and inoculated again in fresh CEFs. This was repeated four times. When 60% of the cells were damaged, the cells were digested and the genomic DNA of the cells was extracted. Put 1 μg of virus-infected CEF genomic DNA and 50 μL of DH10B competent cells in a pre-cooled 0.1 cm electroporation cuvette, and perform electroporation under the conditions of 2000V, 100Ω, 25uF. After electric shock, quickly add 1 mL of SOC liquid medium (containing 0.2 mmol / L glucose, 0.1 mmol / L Mg 2 SO 4 ,...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com